The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy
- 2 May 1999
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 82 (2-3) , 241-250
- https://doi.org/10.1016/s0163-7258(98)00045-x
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cellsGastroenterology, 1998
- A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cellsin vitro andin vivoInternational Journal of Cancer, 1998
- Expression of Epidermal Growth Factor-Related Proteins and Epidermal Growth Factor Receptor in Common Epithelial Ovarian TumorsInternational Journal of Gynecological Pathology, 1997
- A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancerEuropean Journal Of Cancer, 1996
- Epidermal growth factor (EGF) Increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704European Journal Of Cancer, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolinesBreast Cancer Research and Treatment, 1996
- Signalling pathways as target for anticancer drug developmentPharmacology & Therapeutics, 1994
- Toxicity of ligand and antibody‐directed ricin A‐chain conjugates recognizing the epidermal growth factor receptorJournal of Cellular Physiology, 1987
- Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxinExperimental Cell Research, 1986